A Randomized, Placebo-controlled, Blinded Study to Evaluate Efficacy of EB-PA as Protein Amplifier for Skeletal Muscle Strength & Growth - Nil

Vedic Lifesciences Pvt. Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

研究概览

暂无简介。

•1. Males aged 20 to 35 years with active lifestyle with moderate physical activity level as per International Physical Activity Questionnaire
•2. Recreationally gym goer with history of at least 1 month of endurance training (Example - functional exercises)
•3. Not participating in resistance type training (Example external or body weight training) for less than equal to 3 months prior to screening
•4. Body mass index (BMI) 22 to 29.9 kg/m2.
•5. Individuals with a 1-RM strength defined by Upper Body more than equal to 25 Kgs and Lower Body more than Equal to 100 Kgs will be included in the study
•6. Ready to refrain from caffeinated products and intense strength/ endurance exercise for 24 hrs prior to the exercise lab visit
•7. Fasting Blood Glucose Less than Equal to 110 mg/ dl.
•8. Systolic Blood Pressure less than equal to 129 mmHg and Diastolic Blood Pressure Less than equal to 89 mmHg
•9. TSH (thyroid stimulating hormone) more than equal to 0.4 and Less than Equal to 4.9 mIU/L.

•1. Engaged in structured weight training for more than 3 months prior to screening.
•2. Presence of chronic disease.
•3. Changes in body weight more than 4.5 kg (10 pounds) in the past three months as assessed by history.
•4. Subjects diagnosed with hypertension.
•5. Subjects who are diagnosed with Type I and Type II Diabetes Mellitus.
•6. History or presence of clinically significant renal, hepatic, endocrine, biliary, gastrointestinal, pancreatic or neurologic disorders.
•7. Allergy to whey protein or herbal ingredients.
•8. Subjects who have any other disease or condition, or are using any medication, that in the judgement of the investigator would put them at unacceptable risk for participation in the study or may interfere with evaluations in the study or noncompliance with treatment or visits.
•9. Subjects who have been part of a clinical study within 90 days prior to the screening.
•10. Subjects who have used whey or other supplemental proteins anytime in the last 3 months.

发起方